Login / Signup

Non-persistence with anti-platelet therapy and long-term mortality after ischemic stroke: A nationwide study.

Seung Jae KimOh Deog KwonHo Chun ChoiEung-Joon LeeBeLong Cho
Published in: PloS one (2021)
Maintaining antiplatelets for the first 12 months after ischemic stroke reduces long-term risks of both CVD death and non-CVD death.
Keyphrases
  • atrial fibrillation
  • stem cells
  • human health
  • risk assessment
  • mesenchymal stem cells
  • climate change
  • bone marrow
  • smoking cessation